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ABSTRACT: A total synthesis of the (±)-vibralactone has been
achieved in 11 steps and 16% overall yield from malonic acid. Key
steps include a highly diastereoselective allylation of an α-formyl
ester containing an all carbon α-quaternary center, a Pd-catalyzed
deallylative β-lactonization, and an aldehyde-selective Wacker
oxidation of a terminal alkene.
Vibralactone (1) is a terpenoid natural product, whichinhibits pancreatic lipase (IC50 0.4 μg mL−1) with in vitro
activity comparable to that of the FDA approved obesity
therapeutic tetrahydrolipstatin (2, IC50 0.36 μg mL
−1, Figure
1).1,2 Isolation of (−)-vibralactone was ﬁrst reported by Liu et
al. in 2006 by extraction from cultures of Basidiomycete
Borestereum vibrans, leading to the elucidation of its unusual
fused β-lactone structure and discovery of lipase inhibitory
activity.3 Shortly after its isolation, Snider and co-workers
reported total syntheses of racemic and, subsequently,
(−)-vibralactone employing an auxiliary controlled Birch
reduction−prenylation strategy to form the C1 all-carbon
quaternary center with high diastereoselectivity.4,5 Their
asymmetric synthesis was achieved in 11 steps and 4.8% overall
yield from a 2-methoxybenzamide derivative functionalized
with a prolinol chiral auxiliary.
The synthetic route devised by Snider’s group was adopted
by Zeiler et al.6 to provide vibralactone and modiﬁed
derivatives, which were used to label and study the assembly
of two isoforms of caseinolytic peptidase (ClpP1 and ClpP2)
from Listeria monocytogenes.7 Interest in β-lactones as covalent
inhibitors of therapeutically relevant enzymes, combined with
challenges associated with formation of the strained and
sterically congested bicyclic lactone framework of vibralactone,
led us to consider a synthesis of this natural product. Here we
describe an approach to (±)-vibralactone based upon
diastereoselective construction of an acyclic β-hydroxyketone
intermediate 3 and a palladium-catalyzed deallylative cyclization
to form the β-lactone ring.
Our strategy centered on a diastereoselective synthesis of
densely functionalized acyclic intermediate 3, wherein the
relative stereochemistry at the C5 carbinol would be directed
by the adjacent C1 all-carbon quaternary center under
conditions of chelation control (Figure 2). Lactone ring
formation would require inversion at C5 by means of a new
Pd-catalyzed deallylative lactonization, and the cyclopentene
ring closure would employ a modiﬁed aldol-type condensation.
The initial synthetic work commenced with the prenylation
of diallyl malonate to aﬀord 5 (Scheme 1), which participated
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Figure 1. Structures of pancreatic lipase inhibitors (−)-vibralactone
and tetrahydrolipstatin.
Figure 2. Vibralactone synthesis plan.
Scheme 1. Synthesis of Aldehyde 4 from Diallyl Malonate
Letter
pubs.acs.org/OrgLett
© XXXX American Chemical Society A DOI: 10.1021/acs.orglett.6b03007
Org. Lett. XXXX, XXX, XXX−XXX
in an unique malonate dimethoxymethylation reaction induced
under soft enolization conditions using TiCl4, NEt3 and
trimethylorthoformate.8 While this reaction proved eﬃcient
for the production of the diallyl malonate 6, our eﬀorts to
achieve a selective reduction of 6 with DIBAL-H were thwarted
by the formation of multiple products stemming from
hydroalumination of the allyl groups. The predominating
components of the mixture were the desired aldehyde 4 and the
propyl ester 8. The observation of oleﬁn reduction underscored
the highly hindered nature of malonate derivative containing
the all carbon quaternary center, and consequential attenuated
reactivity of the ester carbonyl groups. It is possible that the
ester carbonyl of the postulated hydroaluminated intermediate
7 is activated toward DIBAL-H reduction by internal Lewis acid
activation, accounting for the predominant formation of
aldehyde 4 and propyl ester 8 as a signiﬁcant impurity.
In order to achieve access to the aldehyde 4, our attention
turned to the possibility of chemoselective reduction of a mixed
allyl ester/Weinreb amide derivative (Scheme 2). Selective
reduction of Weinreb amides in the presence of hindered esters
has been reported,9 although we are not aware of any examples
for sterically unbiased systems. The reduction substrate 12 was
prepared from allyl malonate by Weinreb amide formation,
followed by the prenylation−dimethoxymethylation sequence
described above. Submission of Weinreb amide 12 to DIBAL-H
at low temperature resulted in a clean transformation to the
required aldehyde intermediate 4. Importantly, the aldehyde 4
contained the all-carbon quaternary center bearing three
suitably functionalized groups for further selective chemical
transformation toward vibralactone.
Completion of the carbon skeleton of vibralactone required
allylation of aldehyde 4 containing the quaternary all-carbon α-
center (Scheme 2). Linclau and co-workers discussed
substituent and conformational eﬀects controlling diastereose-
lectivity of nucleophilic addition to malonaldehydes containing
a quaternary carbon in the presence of MgBr2.
10 Examples of
diastereoselective additions to α-formyl esters11,12 and α-formyl
ketones13 that contain α-quaternary stereogenic centers have
also been described. In the present work, we applied MgBr2
promoted allylation conditions to aldehyde 4 and we were
delighted to observe the formation of β-hydroxyester 3 as a
single diastereoisomer in 89% yield with no acetal cleavage. The
sense of diastereoselectivity can be explained by a chelation
model where the dimethoxymethyl group blocks nucleophilic
addition to the Si-face of the aldehyde carbonyl.
With highly functionalized intermediate 3 in hand, formation
of the β-lactone was investigated. A classical method entails
lactonization of β-halocarboxylate salts with inversion of
conﬁguration, although Grob fragmentation leading to oleﬁn
byproducts can be a limitation.14 This approach has been
extended to basic hydrolysis of esters, or larger ring lactones,
possessing a leaving group β to the carboxylate intermediate,11
as well as selective monotosylation of β-hydroxy acid dianions
followed by treatment of the resulting acid with NaHCO3.
15
Two-step approaches entailing hydrogenolysis of a benzyl ester
or acid catalyzed ester or amide hydrolysis followed by β-
lactonization under basic conditions have also been de-
scribed.16,17 We considered the possible application of a direct
deallylative cyclization, catalyzed by Pd(0) under less basic
conditions that are more forgiving toward a strained lactone
product (Scheme 3). Therefore, secondary alcohol 3 was
activated by mesylation to aﬀord 13, which was subjected to
palladium-catalyzed deallylation conditions. The outcome was a
remarkably rapid reaction resulting in the desired intra-
molecular substitution to form β-lactone 14 in 95% yield.
Formation of 14 also enabled conﬁrmation of the required
relative stereochemistry (NOESY) for completion of the total
synthesis of vibralactone. To the best of our knowledge, this
deallylative cyclization constitutes a novel approach to the
synthesis of β-lactones, and its potential broader application is
under investigation in our laboratory.
To close the bicycle, oxidative functional group interconver-
sion of the terminal alkene to an aldehyde 15 was needed, and
we were attracted to a recent report from the Grubbs group of
an aldehyde-selective Wacker oxidation using PdCl2(PhCN)2,
CuCl2, and AgNO2.
18 Pleasingly, the methodology delivered
the desired aldehyde 15 in good yield and with a respectable
selectivity of 9:1 over the ketone product, which was not
separated at this stage. The ﬁnal C−C bond formation step of
the synthesis was an aldol-type condensation of the monoacetal
15; Snider and co-workers employed an aldol condensation of a
dialdehyde promoted by Bn2NH·TFA to form a cyclopentene
intermediate in their synthesis of vibralactone.4,5 However,
submission of our substrate 15 to the triﬂuoroacetate salt
Scheme 2. Synthesis of Acyclic Vibralactone Precursor 3
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catalyzed enamine aldolization conditions failed to deliver any
conversion of starting material. Gratifyingly, the more strongly
acidic [Bn2NH2]
+TfO− salt proved highly eﬀective, delivering
an enal (vibralactone C), which was reduced to the allylic
alcohol, completing the synthesis of the natural product
(±)-vibralactone in 75% yield over the ﬁnal two steps.
In summary, we have described a total synthesis of
(±)-vibralactone in 16% overall yield over 11 steps from
malonic acid. Key features of the synthesis include near-perfect
diastereofacial selectivity achieved establishing the C5 stereo-
genic center using a chelation controlled allylation and a novel
Pd-catalyzed β-lactone formation. The approach should be
amenable to the synthesis of vibralactone analogues containing
diﬀerent groups at C1, as well as recently reported vibralactone
oximes isolated from Basidiomycete Boreostereum vibrans.19
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.or-
glett.6b03007.
Experimental details and procedures, compound charac-
terization data, and copies of 1H and 13C NMR spectra





The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
The authors acknowledge ﬁnancial support from EPSRC (EP/
K039466/1, EP/L0505067/1, and EP/P505739/1), the Royal
Society (L. J. B.) for a Dorothy Hodgkin Fellowship, Region
Normandie, and the European Regional Development Fund
(ERDF) for coﬁnancing the AI-Chem project through the
INTERREG IV A France (Channel) - England cross-border
cooperation Programme.
■ REFERENCES
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